Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
Female sex hormone estradiol may protect women against sexually transmitted viral infections

Female sex hormone estradiol may protect women against sexually transmitted viral infections

LJI study could provide important target for autoimmune disease interventions

LJI study could provide important target for autoimmune disease interventions

ZOTEN nanoparticles can help develop natural immunity against genital herpes

ZOTEN nanoparticles can help develop natural immunity against genital herpes

Hormonal contraception may increase susceptibility of women to genital infection

Hormonal contraception may increase susceptibility of women to genital infection

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Scientists reveal mechanism involved in regulation of lymphangiogenesis

Forensic scientists find that HSV-1 strains could be useful for tracing a person's history

Forensic scientists find that HSV-1 strains could be useful for tracing a person's history

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

High school wrestlers have highest number of skin infections

High school wrestlers have highest number of skin infections

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Study shows several Envigo rat models susceptible to genital HSV-2 infection

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Rutgers Cancer Institute scientist leads phase III trial of FDA-approved viral melanoma therapy

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

Over 3.7 billion people under 50 have genital HSV-1 infection, shows WHO report

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens